Moderna and Merck’s Melanoma Vaccine Breakthrough | Charlottesville News

Moderna and Merck just dropped groundbreaking data on a personalized mRNA vaccine for melanoma that slashes the risk of recurrence or spread—offering real hope for patients who’ve already beaten the disease. This isn’t early-stage hype; it’s late-stage results showing the power of tailoring treatments to each person’s unique tumor, training the immune system to hunt down lingering cancer cells. It’s a major leap forward in precision medicine, turning the tide on one of cancer’s most feared relapses—and hinting at a future where treatments are as individualized as the diseases they fight. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e7b26d7a1ed6feaa